Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Broadcom
AVGO
|
$651M |
| 2 |
Monster Beverage
MNST
|
$615M |
| 3 |
Intercontinental Exchange
ICE
|
$556M |
| 4 |
Johnson & Johnson
JNJ
|
$382M |
| 5 |
Applied Materials
AMAT
|
$381M |
Top Sells
| 1 |
Lam Research
LRCX
|
$1.95B |
| 2 |
Texas Instruments
TXN
|
$771M |
| 3 |
Deere & Co
DE
|
$597M |
| 4 |
Meta Platforms (Facebook)
META
|
$543M |
| 5 |
Microsoft
MSFT
|
$510M |
Sector Composition
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.85% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Financials | 9.48% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Amicus Therapeutics
FOLD
$2.46B
| $67.7M | 0.03% |
6,335,235
-6,896,159
| -52% | -$73.7M |
|
327
Exxon Mobil
XOM
$466B
| $67.6M | 0.03% |
577,032
+65,311
| +13% | +$7.65M |
|
328
Liberty Media Series A
FWONA
$22.6B
| $67.5M | 0.03% |
944,266
+69,883
| +8% | +$5M |
|
329
Kirby Corp
KEX
$4.97B
| $67.5M | 0.03% |
551,640
-226,509
| -29% | -$27.7M |
|
330
Fox Class B
FOX
$24.9B
| $66.6M | 0.03% |
1,716,165
+226,867
| +15% | +$8.8M |
|
331
First Industrial Realty Trust
FR
$6.92B
| $66.4M | 0.03% |
1,187,480
-117,429
| -9% | -$6.57M |
|
332
Centene
CNC
$14.2B
| $65.6M | 0.03% |
872,072
-260,785
| -23% | -$19.6M |
|
333
Descartes Systems
DSGX
$9.26B
| $65.1M | 0.03% |
632,168
-1,354
| -0.2% | -$139K |
|
334
Roper Technologies
ROP
$55.8B
| $64.5M | 0.03% |
115,944
+1,375
| +1% | +$765K |
|
335
Perspective Therapeutics
CATX
$257M
| $64M | 0.03% |
4,799,352
+355,685
| +8% | +$4.74M |
|
336
UBS Group
UBS
$128B
| $63.8M | 0.03% |
2,066,849
+37,446
| +2% | +$1.16M |
|
337
Flutter Entertainment
FLUT
$51.9B
| $62.5M | 0.03% |
265,196
-50,003
| -16% | -$11.8M |
|
338
Fiserv
FI
$73.4B
| $62.4M | 0.03% |
347,214
-2,636
| -0.8% | -$474K |
|
339
Hartford Financial Services
HIG
$37B
| $61.8M | 0.03% |
525,853
-21,469
| -4% | -$2.52M |
|
340
Bruker
BRKR
$4.68B
| $61.5M | 0.03% |
890,189
+21,793
| +3% | +$1.51M |
|
341
HDFC Bank
HDB
$361B
| $61.1M | 0.03% |
976,773
-10,694
| -1% | -$669K |
|
342
Neogen
NEOG
$1.25B
| $61.1M | 0.03% |
3,633,007
+1,843
| +0.1% | +$31K |
|
343
Churchill Downs
CHDN
$7.18B
| $61.1M | 0.03% |
451,561
+405
| +0.1% | +$54.8K |
|
344
NRG Energy
NRG
$28.6B
| $60.9M | 0.03% |
668,976
+1,498
| +0.2% | +$136K |
|
345
Agree Realty
ADC
$8.08B
| $60.5M | 0.03% |
803,454
-752,982
| -48% | -$56.7M |
|
346
Cytokinetics
CYTK
$6.34B
| $60.4M | 0.03% |
1,143,830
+167,501
| +17% | +$8.84M |
|
347
Alnylam Pharmaceuticals
ALNY
$59.2B
| $60.3M | 0.03% |
219,337
-30,103
| -12% | -$8.28M |
|
348
ATS Corp
ATS
$2.67B
| $60.2M | 0.03% |
2,072,854
+2,854
| +0.1% | +$82.9K |
|
349
On Holding
ONON
$14.9B
| $60.1M | 0.03% |
1,197,420
+1,088
| +0.1% | +$54.6K |
|
350
Citigroup
C
$176B
| $59.7M | 0.03% |
952,909
+702,300
| +280% | +$44M |
|